CYCLOCORT Drug Patent Profile

Which patents cover Cyclocort, and when can generic versions of Cyclocort launch?

Cyclocort is a drug marketed by Astellas and is included in three NDAs.

The generic ingredient in CYCLOCORT is amcinonide. There is one drug master file entry for this compound. Four suppliers are listed for this compound. Additional details are available on the amcinonide profile page.

DrugPatentWatch^® Litigation and Generic Entry Outlook for Cyclocort

A generic version of CYCLOCORT was approved as amcinonide by TARO PHARM INDS on May 31^st, 2002.

Summary for CYCLOCORT

US Patents:	0
Applicants:	1
NDAs:	3
Raw Ingredient (Bulk) Api Vendors:	1
Patent Applications:	8,272
DailyMed Link:	CYCLOCORT at DailyMed

US Patents and Regulatory Information for CYCLOCORT

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Astellas	CYCLOCORT	amcinonide	CREAM;TOPICAL	018116-001	Approved Prior to Jan 1, 1982		DISCN	Yes	No
Astellas	CYCLOCORT	amcinonide	OINTMENT;TOPICAL	018498-001	Approved Prior to Jan 1, 1982		DISCN	Yes	No
Astellas	CYCLOCORT	amcinonide	CREAM;TOPICAL	018116-002	Approved Prior to Jan 1, 1982		DISCN	Yes	No

Expired US Patents for CYCLOCORT

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Astellas	CYCLOCORT	amcinonide	CREAM;TOPICAL	018116-002	Approved Prior to Jan 1, 1982	4,158,055
Astellas	CYCLOCORT	amcinonide	OINTMENT;TOPICAL	018498-001	Approved Prior to Jan 1, 1982	4,158,055

International Patents for CYCLOCORT

See the table below for patents covering CYCLOCORT around the world.

Country	Patent Number	Title	Estimated Expiration
Australia	7073674
Belgium	818929
Switzerland	601353